Section Arrow
VIGL.NASDAQ
- Vigil Neuroscience
Quotes are at least 15-min delayed:2025/03/28 00:16 EDT
Last
 1.89
+0.09 (+5.00%)
Day High 
1.94 
Prev. Close
1.8 
1-M High
2.75 
Volume 
147.64K 
Bid
1.86
Ask
1.9
Day Low
1.74 
Open
1.82 
1-M Low
1.73 
Market Cap 
84.01M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.92 
20-SMA 2.14 
50-SMA 2.33 
52-W High 6.06 
52-W Low 1.49 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.07/-0.88
Enterprise Value
95.92M
Balance Sheet
Book Value Per Share
1.53
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed:2025/03/28 00:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.